The influence of persimmon peel and persimmon pulp on the lipid metabolism and antioxidant activity of rats fed cholesterol

Journal of Nutritional Biochemistry

Volumn 9, Issue 4, 1998, Pages 223-227

  Gorinstein, Shela ^b   Kulasek, Gustaw W ^a   Bartnikowska, Elzbieta ^a   Leontowicz, Maria ^a   Zemser, Marina ^b   Morawiec, Marek ^a   Trakhtenberg, Simon ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Department of Human Nutrition Dept Anim Physiol Warsaw A ^*  (Poland)

^c KAPLAN HOSPITAL   (Israel)

Author keywords

Antioxidant effects; Hypocholesterolemic; Peel; Persimmon; Pulp; Rats

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; FRUIT; HYPOCHOLESTEROLEMIA; LIPID METABOLISM; MALE; NONHUMAN; RAT;

ANIMALIA; DIOSPYROS VIRGINIANA; RATTUS NORVEGICUS;

EID: 0031922065     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(98)00003-5     Document Type: Article

References (28)

1. Hennekens C.H., Gaziano J.M. Antioxidants and heart disease epidemiology and clinical evidance . Clin. Cardiol. 16:1993;110-115.
2. Gaziano J.M. Antioxidant vitamins and coronary artery disease risk. Am. J. Med. 97:1994;18S-21S, 22S\N28S.
3. Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., Guidollet J., Touboul P., Delaye J. Mediterranean alpha-linolic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 343:1994;1454-1459.
4. Parfitt V.J., Rubba P., Bolton C., Marrota G., Hartog M., Mancini M. A comparison of antioxidant status and free radical peroxidation of plasma lipoproteins in healthy young persons from Naples and Bristol. Eur. Heart J. 15:1994;871-876.
5. Riemersma R.A., Wood D.A., Macintyre C.C.A., Elton A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentration of vitamins A, C and E and carotene. Lancet. 337:1993;1-5.
6. Gey K.F., Stahelin H.B., Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke. Basel prospective study. Clin. Investig. 71:1993;3-6.
7. Jessup W., Rankin S.M., Whalley C.V., Hoult J.R., Scott J., Leake D.S. α-Tocopherol consumption during low-density-lipoprotein oxidation. Biochem. J. 263:1990;399-405.
8. Frankel E.N., Kanner J., German G.B., Parks E., Kinsella J. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
9. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL-C by resveratol. Lancet. 341:1993;1103-1104.
10. Morel L., Lescoat G., Cillard P., Cillard J. Role of flavonoids and iron chelation in antioxidant action. Methods Enzymol. 234:1994;437-443.
11. Hartog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhouy D. Dietary antioxidant flavonoids and risk of coronary heart disease the Zutphen Elderly Study . Lancet. 342:1993;1007-1011.
12. Gross, J. (1987). Pigments in Fruits (B.S. Schweiger, ed.), p. 87, 127, 155, 181, 243-245, Academic Press, New York, NY USA.
13. Gorinstein S., Zemser M., Weitz M., Halevy S., Deutsch J., Tilus K., Feintuch D., Guerra N., Fishman M., Bartnikowska E. Fluorometric analysis of phenolics in Persimmon. Biosci. Biotech. Biochem. 58:1994;1087-1092.
14. Manual of Laboratory Operations, Lipid Research Clinic Program. (1974). Revised, DHEW Publ. No (NIH), 1982, 75, 628-635.
15. Anitschkow N., Chalatow S. Uber experimentalle Cholesterinsteatose und ihre Bedeutung fur einiger pathologischer Processe. Ztb. f. allg. Path. u. path Anat. 24:1913;1-9.
16. Doyle J.T., Heslin A.S., Hilleboe H.E., Formal N. Early diagnosis of ischemic heart disease. N. Engl. J. Med. 261:1959;1096-1101.
17. MacMahon S., Peto R., Cutler J., Collins R., Newton J., Abbott R., Godwon J., Dyer A., Stamler J. Blood pressure, stroke and coronary artery disease. Part 1. Prolonged differences in blood pressure prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
18. Buechley R.W., Drake R.M., Breslow L. Relationship of amount of cigarette smoking to coronary heart disease mortality rates in men. Circulation. 18:1958;1085-1090.
19. Dawber T.R., Kannel W.B., Revotslie N., Stokes J., Kogan A., Gordon T. Some factors associated with development of coronary hart disease six years of follow-up experience in the Framingham study . Am. J. Public Health. 49:1959;1349-1356.
20. Stamler J., Vaccaro O., Neaton J.D., Wentworh D. Diabetes Care. 16:1993;434-444.
21. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C., Rand L.I., Christlieb A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am. J. Cardiol. 59:1987;750-755.
22. Cassel J., Heyden S., Bartel A.G., Kaplan B.H., Tyroler H.A., Cornoni J.C., Hames C.G. Occupation and physical activity and coronary heart disease. Arch. Int. Med. 128:1971;920-928.
23. Morris J.N., Everitt M.G., Pollard R., Chave S.W.P., Semmence A.M. Vigorous exercise in leisure-time protection against coronary heart disease . Lancet. 8206:1980;1207-1210.
24. Steinberg D., Parthasarathy S., Carew T., Khoo J., Witzum J. Beyond cholesterol modifications of low density lipoprotein that increase its atherogenicity . N. Engl. J. Med. 320:1989;915-924.
25. Witzum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
26. Aviram M. Modified form of low density lipoprotein and atherosclerosis. Atherosclerosis. 98:1993;1-9.
27. Steinbrecher U.P., Zhang H., Longheed. Role of oxidative modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
28. Rimm E.B., Stampfer M.J., Ascherio A., Giovannuci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary disease in men. N. Engl. J Med. 328:1993;1450-1456.